MX2024009755A - Metodos de purificacion de un producto. - Google Patents
Metodos de purificacion de un producto.Info
- Publication number
- MX2024009755A MX2024009755A MX2024009755A MX2024009755A MX2024009755A MX 2024009755 A MX2024009755 A MX 2024009755A MX 2024009755 A MX2024009755 A MX 2024009755A MX 2024009755 A MX2024009755 A MX 2024009755A MX 2024009755 A MX2024009755 A MX 2024009755A
- Authority
- MX
- Mexico
- Prior art keywords
- product
- methods
- purifying
- affinity chromatography
- purification
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
- C07K16/248—IL-6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263267810P | 2022-02-10 | 2022-02-10 | |
| PCT/US2023/062322 WO2023154822A2 (en) | 2022-02-10 | 2023-02-09 | Methods of purifying a product |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2024009755A true MX2024009755A (es) | 2024-08-20 |
Family
ID=87521638
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2024009755A MX2024009755A (es) | 2022-02-10 | 2023-02-09 | Metodos de purificacion de un producto. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230250133A1 (https=) |
| EP (1) | EP4476237A2 (https=) |
| JP (1) | JP2025505696A (https=) |
| KR (1) | KR20240142564A (https=) |
| CN (1) | CN119032099A (https=) |
| AU (1) | AU2023217074A1 (https=) |
| CA (1) | CA3251000A1 (https=) |
| IL (1) | IL314472A (https=) |
| MX (1) | MX2024009755A (https=) |
| WO (1) | WO2023154822A2 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015035342A2 (en) | 2013-09-08 | 2015-03-12 | Oligasis Llc | Factor viii zwitterionic polymer conjugates |
| CA3059938A1 (en) | 2017-04-14 | 2018-10-18 | Kodiak Sciences Inc. | Complement factor d antagonist antibodies and conjugates thereof |
| EP3758737A4 (en) | 2018-03-02 | 2022-10-12 | Kodiak Sciences Inc. | IL-6 ANTIBODIES AND FUSION CONSTRUCTS AND CONJUGATES THEREOF |
| CA3157509A1 (en) | 2019-10-10 | 2021-04-15 | Kodiak Sciences Inc. | Methods of treating an eye disorder |
| WO2025073922A1 (en) * | 2023-10-04 | 2025-04-10 | Sartorius Bia Separations D.O.O. | Enhanced chromatographic separations of components in a mixture by employing chaotropic elution |
| WO2025184423A1 (en) * | 2024-02-29 | 2025-09-04 | Kodiak Sciences Inc. | Cell-surface-targeting-domain-polymer-payload conjugate |
| WO2026055308A1 (en) * | 2024-09-06 | 2026-03-12 | Merck Sharp & Dohme Llc | Multivalent fzd4, wnt co-receptor, and vegf receptor molecules and uses thereof |
| US20260092125A1 (en) * | 2024-09-06 | 2026-04-02 | Eyebiotech Limited | Multivalent fzd4, wnt co-receptor, and vegf binding molecules and uses thereof |
| WO2026075981A1 (en) * | 2024-10-01 | 2026-04-09 | Regeneron Pharmaceuticals, Inc. | Methods of analyzing heterodimeric proteins |
| CN119454939A (zh) * | 2024-11-28 | 2025-02-18 | 北海康成(苏州)生物制药有限公司 | 一种欧莫扑拜单抗原液及其制备方法 |
| CN119524125A (zh) * | 2024-11-28 | 2025-02-28 | 北海康成(苏州)生物制药有限公司 | 一种欧莫扑拜单抗原液的生产方法及欧莫扑拜单抗原液 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7045314B2 (en) * | 2000-04-04 | 2006-05-16 | Baxter International Inc. | Method for the production of bacterial toxins |
| WO2010147686A2 (en) * | 2009-03-11 | 2010-12-23 | Wyeth Llc | Methods of purifying small modular immunopharmaceutical proteins |
| JP6162707B2 (ja) * | 2011-10-24 | 2017-07-12 | ハロザイム インコーポレイテッド | 抗ヒアルロナン剤治療のためのコンパニオン診断およびその使用方法 |
| CN105899540B (zh) * | 2014-01-03 | 2020-02-07 | 豪夫迈·罗氏有限公司 | 双特异性抗-半抗原/抗-血脑屏障受体的抗体、其复合物及它们作为血脑屏障穿梭物的应用 |
| MX380658B (es) * | 2014-01-15 | 2025-03-11 | Hoffmann La Roche | Variantes de region fc con union mejorada de la proteina a. |
| EP3054007A1 (en) * | 2015-02-09 | 2016-08-10 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Recombinant adeno-associated virus particle purification comprising an immuno-affinity purification step |
| PE20181363A1 (es) * | 2015-09-23 | 2018-08-27 | Genentech Inc | Variantes optimizadas de anticuerpos anti-vegf |
| KR20250057128A (ko) * | 2015-12-30 | 2025-04-28 | 코디악 사이언시스 인코포레이티드 | 항체 및 이의 접합체 |
| EP3758737A4 (en) * | 2018-03-02 | 2022-10-12 | Kodiak Sciences Inc. | IL-6 ANTIBODIES AND FUSION CONSTRUCTS AND CONJUGATES THEREOF |
| US20210254073A1 (en) * | 2020-02-04 | 2021-08-19 | Cornell University | Methods for capture and analysis of macromolecular complexes |
-
2023
- 2023-02-09 AU AU2023217074A patent/AU2023217074A1/en active Pending
- 2023-02-09 US US18/166,755 patent/US20230250133A1/en active Pending
- 2023-02-09 MX MX2024009755A patent/MX2024009755A/es unknown
- 2023-02-09 IL IL314472A patent/IL314472A/en unknown
- 2023-02-09 KR KR1020247030267A patent/KR20240142564A/ko active Pending
- 2023-02-09 CN CN202380033420.7A patent/CN119032099A/zh active Pending
- 2023-02-09 JP JP2024547315A patent/JP2025505696A/ja active Pending
- 2023-02-09 EP EP23753671.9A patent/EP4476237A2/en active Pending
- 2023-02-09 CA CA3251000A patent/CA3251000A1/en active Pending
- 2023-02-09 WO PCT/US2023/062322 patent/WO2023154822A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| CA3251000A1 (en) | 2023-08-17 |
| KR20240142564A (ko) | 2024-09-30 |
| JP2025505696A (ja) | 2025-02-28 |
| IL314472A (en) | 2024-09-01 |
| WO2023154822A2 (en) | 2023-08-17 |
| AU2023217074A1 (en) | 2024-08-15 |
| CN119032099A (zh) | 2024-11-26 |
| WO2023154822A3 (en) | 2023-09-21 |
| EP4476237A2 (en) | 2024-12-18 |
| WO2023154822A8 (en) | 2024-04-04 |
| US20230250133A1 (en) | 2023-08-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2024009755A (es) | Metodos de purificacion de un producto. | |
| De Luca et al. | Downstream processing of therapeutic peptides by means of preparative liquid chromatography | |
| MX2015005178A (es) | Purificacion de polipeptidos usando ultrafiltracion de flujo tangencial de etapa doble. | |
| Roe | Protein purification applications: a practical approach | |
| PL374311A1 (en) | Methods for purifying protein | |
| WO2002083710A3 (en) | Removal of bacterial endotoxin in a protein solution by immobilized metal affinity chromatography | |
| MX2013006611A (es) | Tratamiento de formaciones iliticas al usar un agente quelante. | |
| MX2012001263A (es) | Metodo para purificar adamts13 recombinante y otras proteinas y sus composiciones. | |
| RU2011137030A (ru) | Способы очистки малых модулярных иммунофармацевтических белков | |
| CN109096379B (zh) | 一种枯草芽孢杆菌amep412蛋白的新功能及其抗菌肽的鉴定 | |
| US20250340589A1 (en) | Purifying antibodies | |
| Luong et al. | A continuous affinity ultrafiltration process for trypsin purification | |
| Dyr et al. | Separation used for purification of recombinant proteins | |
| SE8402861L (sv) | Rening av biologiskt material | |
| KR960701096A (ko) | 그룹 B 스트렙토코커스의 많은 균주들에 대한 면역성을 제공하는 세포 표면 단백질인 Rib 단백질, 그 단백질의 정제방법, 시약키트 및 제약조성물(PROTEIN RIB. A CELL SURFACE PROTEIN THAT CONFERS IMMUNITY TO MANY STRAINS OF THE GROUP B STREPTOCOCCUS; PROCESS FOR PURIFICATION OF THE PROTEIN, PEAGENT KIT AND PHARMACEUTICAL COMPOSITION) | |
| Gräslund et al. | Integrated strategy for selective expanded bed ion-exchange adsorption and site-specific protein processing using gene fusion technology | |
| Balekjian et al. | Histones isolated from human parotid fluid | |
| Mönster et al. | One-step-purification of penicillin G amidase from cell lysate using ion-exchange membrane adsorbers | |
| Garmidolova et al. | Food-derived bioactive peptides-methods for purification and analysis | |
| CN105112394A (zh) | 一种能降解黄曲霉毒素b1的裂解酶的分离纯化方法 | |
| Recio et al. | Method for the production of antibacterial peptides from biological fluids at an ionic membrane. Application to the isolation of nisin and caprine lactoferricin | |
| Karabel’skii et al. | Purification of the chimeric protein alburon16 from a culture medium of the yeast Pichia pastoris | |
| CN116082471B (zh) | 一种Cth TerA内含肽变体及其在生物法制备四肽-7中的应用 | |
| Miller et al. | Biochemical characterization of the antimicrobial histone released by deoxyribonuclease and lactic acid | |
| GEAP202516778A (en) | Arginine wash in protein purification |